BPTQ is a potent inhibitor of VEGFR1/Flt-1 and CHK2 (IC50 = 0.54 and 1.70 µmol/L, respectively); a DNA intercalating agent with anticancer activity; inhibits HL-60 cell proliferation in S and G2/M phases (IC50 = 12 µmol/L); and induces mitochondrial-mediated apoptosis by reducing mitochondrial membrane potential, increasing the Bax:Bcl-2 ratio, and activating caspases.